HU0105379D0 - Lawsonia intracellularis vaccine - Google Patents

Lawsonia intracellularis vaccine

Info

Publication number
HU0105379D0
HU0105379D0 HU0105379A HUP0105379A HU0105379D0 HU 0105379 D0 HU0105379 D0 HU 0105379D0 HU 0105379 A HU0105379 A HU 0105379A HU P0105379 A HUP0105379 A HU P0105379A HU 0105379 D0 HU0105379 D0 HU 0105379D0
Authority
HU
Hungary
Prior art keywords
relates
lawsonia intracellularis
nucleic acid
detection
dna
Prior art date
Application number
HU0105379A
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Paul Vermeij
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HU0105379D0 publication Critical patent/HU0105379D0/hu
Publication of HUP0105379A2 publication Critical patent/HUP0105379A2/hu
Publication of HUP0105379A3 publication Critical patent/HUP0105379A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0105379A 2000-12-20 2001-12-19 Lawsonia intracellularis vaccine HUP0105379A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204660 2000-12-20

Publications (3)

Publication Number Publication Date
HU0105379D0 true HU0105379D0 (en) 2002-02-28
HUP0105379A2 HUP0105379A2 (hu) 2003-01-28
HUP0105379A3 HUP0105379A3 (en) 2004-07-28

Family

ID=8172486

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105379A HUP0105379A3 (en) 2000-12-20 2001-12-19 Lawsonia intracellularis vaccine

Country Status (12)

Country Link
US (2) US6921536B2 (hu)
EP (2) EP1586646B1 (hu)
JP (1) JP4237960B2 (hu)
AT (2) ATE330013T1 (hu)
AU (1) AU783210B2 (hu)
CA (1) CA2365494A1 (hu)
DE (2) DE60144201D1 (hu)
DK (2) DK1219711T3 (hu)
ES (2) ES2266090T3 (hu)
HU (1) HUP0105379A3 (hu)
PL (1) PL205964B1 (hu)
PT (1) PT1219711E (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1219711T3 (da) * 2000-12-20 2006-09-25 Intervet Int Bv Lawsonia Intracellularis vaccine
CA2499885C (en) 2002-05-29 2010-04-20 Yamasa Corporation Novel polyphosphate:amp phosphotransferase
US7662390B2 (en) 2003-09-12 2010-02-16 Intarvet International B.V. Lawsonia intracellularis subunit vaccine
MXPA06008217A (es) * 2004-01-22 2007-05-23 Intervet Int Bv Vacunas con subunidad de lawsonia intracellularis.
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
EP1609870A1 (en) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Method of diagnosing lawsonia intracellularis
JP2008520231A (ja) * 2004-11-24 2008-06-19 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓの培養方法
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006113782A2 (en) * 2005-04-18 2006-10-26 Boehringer Ingelheim Vetmedica, Inc. Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
EP3253409B1 (en) 2015-02-04 2020-05-06 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
US10265392B2 (en) 2015-02-04 2019-04-23 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
JP7088835B2 (ja) * 2015-10-16 2022-06-21 カンザス ステイト ユニバーシティ リサーチ ファウンデーション ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.
CN113528683A (zh) * 2021-07-09 2021-10-22 南京农业大学 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310993A (en) 1980-01-07 1982-01-19 Louvers & Dampers, Inc. Louver assembly
EP0473210B1 (en) 1990-07-30 1994-04-13 Akzo Nobel N.V. Recombinant Marek's disease virus
WO1993004163A1 (en) 1991-08-23 1993-03-04 Massachusetts Institute Of Technology Strain of chlamydia
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
FR2714074B1 (fr) 1993-12-20 1996-03-01 Pasteur Institut Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US7022328B1 (en) * 1995-11-30 2006-04-04 Australian Pork Limited Therapeutic and diagnostic compositions
CA2372105A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
JP2003501013A (ja) 1999-05-13 2003-01-14 ファイザー プロダクツ インコーポレーティッド ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
EP1183268A4 (en) * 1999-05-13 2003-01-02 Australian Pork Ltd LAWSONIA DERIVED GENES AND RELATED OMPHPOLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
WO2000069904A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
DK1219711T3 (da) * 2000-12-20 2006-09-25 Intervet Int Bv Lawsonia Intracellularis vaccine

Also Published As

Publication number Publication date
EP1586646A2 (en) 2005-10-19
PL205964B1 (pl) 2010-06-30
JP2003000276A (ja) 2003-01-07
EP1586646B1 (en) 2011-03-09
US20050069559A1 (en) 2005-03-31
AU783210B2 (en) 2005-10-06
JP4237960B2 (ja) 2009-03-11
DK1219711T3 (da) 2006-09-25
ES2266090T3 (es) 2007-03-01
US20050250150A1 (en) 2005-11-10
PL351277A1 (en) 2002-07-01
DE60120621T2 (de) 2006-12-14
CA2365494A1 (en) 2002-06-20
US6921536B2 (en) 2005-07-26
US7491401B2 (en) 2009-02-17
AU9737101A (en) 2002-06-27
DK1586646T3 (da) 2011-06-27
EP1219711A3 (en) 2002-11-06
PT1219711E (pt) 2006-10-31
EP1586646A3 (en) 2007-08-01
DE60120621D1 (de) 2006-07-27
HUP0105379A2 (hu) 2003-01-28
EP1219711A2 (en) 2002-07-03
DE60144201D1 (de) 2011-04-21
HUP0105379A3 (en) 2004-07-28
ATE330013T1 (de) 2006-07-15
EP1219711B1 (en) 2006-06-14
ATE501258T1 (de) 2011-03-15
ES2360225T3 (es) 2011-06-02

Similar Documents

Publication Publication Date Title
HU0105379D0 (en) Lawsonia intracellularis vaccine
MXPA06008217A (es) Vacunas con subunidad de lawsonia intracellularis.
DE69739981D1 (de) Streptococcus pneumoniae-Antigene und Impfstoffe
WO2002080851A3 (en) Chimeric vaccines
WO2000005378A3 (en) Streptococcus suis vaccines and diagnostic tests
DE60131858D1 (de) Borrelia burgdorferi rekombinante genkonstrukte
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2005026200A3 (en) Lawsonia intracellularis subunit vaccine
WO2003058248A3 (en) Diagnostics and vaccines for mycrobacterium paratuberculosis infections
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
ZA200602107B (en) Piroplasmid vaccine
PT1176192E (pt) Vacina de helicobacter felis
WO2004024769A3 (en) Ostertagia vaccine
HUP0200832A2 (hu) Babesia canis oltóanyag
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INTERVET INTERNATIONAL B.V., NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FD9A Lapse of provisional protection due to non-payment of fees